Domestic Policy Caucus Signs on Coalition Letter to Legislators to Stop 340B Expansion in North Dakota

The Domestic Policy Caucus joins American Free Enterprise, AFP North Dakota, and North Dakota Watchdog Network to warn against House Bill 1473, as it would expand the federal 340B Rx drug program and cost North Dakota taxpayers and employers millions of dollars.

The following are key findings from the 2025 financial impact report from IQVIA, which analyzes the cost of forgone rebates to employers and state/local governments: 

• Nationally, forgone rebates on prescriptions filled with 340B pricing increased commercial employer costs by over $6.6B and state and local government plans by $1B in 2023.

• In North Dakota, forgone rebates on 340B prescriptions increased commercial employer costs by over $53.4M and state and local government plans by $9.5M in 2023.

• For North Dakota, 340B contract pharmacy mandate bills would further increase this cost by $13.9M for commercial employers and $2.5M for state and local governments.

Read the full letter here.